| Code | 18423 | ||||||||||
| MA number | 13/0823/95-S | ||||||||||
| Product Form: | sol inj 6x2 ml/6 mg (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Sanofi Winthrop Industrie, France | ||||||||||
| Therapeutic Class: | 13 - ANTIARRYTHMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 14.12.1995 |
| SPC: |
SPC_Adenocor_sol inj_10_2023.pdf
|
| PIL: |
PIL_Adenocor_sol inj_10_2023.pdf
|
| Safety feature | Yes |
| Data update: | 11.04.2018 |
